Publications

Publications

Filter Results: (74) Arrow Down

Show Results For

← Page 4 of 74 Results
  • 01 Aug 2017
  • First Look

First Look at New Research and Ideas, August 1

Transformation at Eli Lilly & Co. (A) Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly... View Details
Keywords: Sean Silverthorne
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

Bastianelli said. Also missing are the partnerships between academic and business communities that are common in the States, added Thomas G. Wellner, executive director of marketing at Eli Lilly and... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 24 Mar 2020
  • Research & Ideas

These Coronavirus Heroes Show Us How Crisis Leadership Works

for COVID-19 and is currently able to run 1,000 tests per day. David A. Ricks, CEO of Eli Lilly. Under Ricks’ guidance, Lilly has teamed with AbCellera Biologics to find antibodies to disarm COVID-19.... View Details
Keywords: by Bill George; Health
  • 29 May 2001
  • Research & Ideas

Genomics: Can We Start Making Money Now?

Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate... View Details
Keywords: by Sean Silverthorne
  • 29 Jun 2022
  • Blog Post

Harvard Business School Announces the 2022-2023 Blavatnik Fellows

medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin Wolfe, PhD. Hunter became... View Details
  • 06 Feb 2007
  • First Look

First Look: February 6, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707486 Corporate Venture Capital at Eli Lilly Harvard Business School Case 806-092 Reviews the role of corporate venture capital and its history... View Details
Keywords: Martha Lagace
  • 13 Jan 2003
  • Research & Ideas

Making Biotech Work as a Business

influenced the industry by proving that intellectual property could be monetized through alliances with big pharmaceutical partners, according to Pisano. Genentech cut its first deal with Eli Lilly in 1982... View Details
Keywords: by Martha Lagace; Biotechnology; Health; Technology
  • 20 Apr 2016
  • Research & Ideas

When CEOs Become Activists

which executive activism affected not only public opinion but also customer perceptions. Apple CEO Cook’s actions around the RFRA debate particularly intrigued the researchers. “You can see a business reason why the CEOs of Eli View Details
Keywords: by Carmen Nobel; Technology; Publishing
  • 18 Dec 2012
  • First Look

First Look: December 18

note:http://hbr.org/search/813096-PDF-ENG Cialis Lifecycle Management: Lilly's BPH Dilemma Ofek, Elie, and Natalie KindredHarvard Business School Case 513-005 How should Eli Lilly further develop and market... View Details
Keywords: Carmen Nobel
  • 28 Apr 2009
  • First Look

First Look: April 28, 2009

the company submits to the Food and Drug Administration. The case reviews Targanta's origins and "de-risking" of oritavancin, an antibiotic therapy for drug-resistant infections that was first invented at Eli View Details
Keywords: Martha Lagace